key: cord-0947749-87trjsz6
authors: Beressa, Tamirat Bekele; Deyno, Serawit; Mtewa, Andrew G.; Aidah, Namuli; Tuyiringire, Naasson; Lukubye, Ben; Weisheit, Anke; Tolo, Casim Umba; Ogwang, Patrick Engeu
title: Potential Benefits of Antiviral African Medicinal Plants in the Management of Viral Infections: Systematic Review
date: 2021-12-24
journal: Front Pharmacol
DOI: 10.3389/fphar.2021.682794
sha: c1d52770fd0a97428c968e288ecb6f4ff245e302
doc_id: 947749
cord_uid: 87trjsz6

Background: Viruses cause various human diseases, some of which become pandemic outbreaks. This study synthesized evidence on antiviral medicinal plants in Africa which could potentially be further studied for viral infections including Coronavirus disease 2019 (COVID-19) treatment. Methods: PUBMED, CINAHIL, Scopus, Google Scholar, and Google databases were searched through keywords; antiviral, plant, herb, and Africa were combined using “AND” and “OR”. In-vitro studies, in-vivo studies, or clinical trials on botanical medicine used for the treatment of viruses in Africa were included. Results: Thirty-six studies were included in the evidence synthesis. Three hundred and twenty-eight plants were screened for antiviral activities of which 127 showed noteworthy activities against 25 viral species. These, were Poliovirus (42 plants), HSV (34 plants), Coxsackievirus (16 plants), Rhinovirus (14plants), Influenza (12 plants), Astrovirus (11 plants), SARS-CoV-2 (10 plants), HIV (10 plants), Echovirus (8 plants), Parvovirus (6 plants), Semiliki forest virus (5 plants), Measles virus (5 plants), Hepatitis virus (3 plants), Canine distemper virus (3 plants), Zika virus (2 plants), Vesicular stomatitis virus T2 (2 plants). Feline herpesvirus (FHV-1), Enterovirus, Dengue virus, Ebola virus, Chikungunya virus, Yellow fever virus, Respiratory syncytial virus, Rift Valley fever virus, Human cytomegalovirus each showed sensitivities to one plant. Conclusion: The current study provided a list of African medicinal plants which demonstrated antiviral activities and could potentially be candidates for COVID-19 treatment. However, all studies were preliminary and in vitro screening. Further in vivo studies are required for plant-based management of viral diseases.

Viruses cause various human diseases of which several such as Ebola, HIV/AIDS, and Hepatitis B are hard to treat. Many pandemic outbreaks in world history were caused by a viral infection. The Spanish flu pandemic of 1918, the deadliest in history, infected an estimated 500 million people worldwide; which is about one-third of the planet's population, and killed an estimated 20 million to 50 million people (1). In recent years, pandemics have arisen and have also been contained using various approaches. For example, Ebola virus outbreak between 2013 and 2016 with 11323 deaths (Trilla et al., 2008) , Coronavirus (Severe Acute Respiratory Syndrome (SARS) with deaths of 229 (World Health Organization, 2003) , Middle East respiratory syndrome (MERS) as of May 31, 2015, which had 483 (40%) mortality (Zumla et al., 2015) are some of the recorded global pandemics. Since December 2019 the world is suffering from Coronavirus disease 2019 (COVID-19) with more than 197 million people infected and more than 4, 219, 861 deaths as of August 4, 2021 (World Health Organization, 2020 .

The use of natural medicinal agents dates back to human prehistory where plants formed the basis of traditional medicine (TM) systems. Traditional medicine refers to health practices, approaches, knowledge, and beliefs incorporating plant, animal, and mineral-based medicines, spiritual therapies, manual techniques, and exercises which are applied singularly or in combination to treat or to diagnose and prevent illnesses or maintain well-being (World Health Assembly, 2003) . Traditional medicine has a high influence on the African health system with an estimated 80% of the population depending on TM practice for primary health care purposes (World Health Organization, 2005) . The availability and affordability of the TM aligned with inherited knowledge of the practice in local communities might have contributed to their wide use (Fennell et al., 2004) .

Several herbal medicines have been used to treat viral infections traditionally for a long time. Some studies have reported the inhibitory effect of medicinal plant extracts against several viruses. Some of these studies were conducted on HIV, herpes simplex virus, hepatitis B virus, and poliovirus. For example, ethnobotanical studies in Africa described the treatment of viral hepatitis with traditional medicine in Africa (Vlietinck et al., 1995; Sindambiwe et al., 1999; Cos et al., 2002a; Amenu, 2007; Abera, 2014; Traore et al., 2018) . Furthermore, plants have been reported to have antiviral potential against conventional medicine-resistant strains of viruses (Serkedjieva, 2003) . Nine traditional Chinese botanicals were optimized to treat the symptoms of SARS during its outbreak (Zhang et al., 2004) . In another study, small molecules from natural compounds have been screened and confirmed to inhibit important proteins in SARS or MERS coronavirus . Despite having lots of endemic knowledge and practice on African herbal medicine, there is a paucity of scientific evidence on their efficacy and safety. This study aimed to summarize the evidence on antiviral medicinal plants in Africa which could potentially be further studied for COVID-19 treatment.

This review was conducted using database searches and followed statements for Reporting Systematic Reviews and Meta-Analyses (Liberati et al., 2009 ).

Data were collected from MEDLINE/PUBMED, CINAHIL, Google Scholar, and Scopus databases. No language limitations were applied to reduce selection bias and Google was used to translate articles published in other languages than English. The search strategy used the following terms with appropriate Boolean operators; ("virus diseases" OR ("virus" AND "diseases") OR "virus diseases" OR ("viral" AND "infection") OR "viral infection") OR ("poliovirus" OR "poliovirus" OR HSV OR ("simplexvirus" OR "simplexvirus" OR ("herpes" AND "simplex" AND "virus") OR "herpes simplex virus") OR ("enterovirus" OR "enterovirus" OR "coxsackievirus" OR ("influenza, human" OR ("influenza" AND "human") OR "human influenza" OR "influenza") OR (astro AND ("viruses" OR "viruses" OR "virus")) OR ("parvovirus" OR "parvovirus") OR ("rhinovirus" OR "rhinovirus") OR ("enterovirus b, human" OR "human enterovirus b" OR "echovirus") OR ("hiv"OR "hiv") OR ("hiv"OR "hiv" OR ("human" AND "immunodeficiency" AND "virus") OR "human immunodeficiency virus") OR (semiliki AND ("forests"OR "forests" OR "forest") AND ("viruses"OR "viruses" OR "virus")) OR ("measles virus"OR ("measles" AND "virus") OR "measles virus") OR ("hepatitis viruses"OR ("hepatitis" AND "viruses") OR "hepatitis viruses" OR ("hepatitis" AND "virus") OR "hepatitis virus") OR ("zika virus"OR ("zika" AND "virus") OR "zika virus") OR (("vesicular stomatitis indiana virus"OR ("vesicular" AND "stomatitis" AND "indiana" AND "virus") OR "vesicular stomatitis indiana virus" OR ("vesicular" AND "stomatitis" AND "virus") OR "vesicular stomatitis virus") AND T2) OR ("coronavirus disease 2019" OR "COVID-2019″) AND "herbal medicine" OR "traditional medicine" OR "oriental medicine" OR "Chinese medicine" OR "African medicine" OR "herbal formula" OR herb AND") AND (" AND ("africa"OR "africa") AND "OR" AND (("african continental ancestry group"OR ("african" AND "continental" AND "ancestry" AND "group") OR "african continental ancestry group" OR "african") AND countries).

We included original research articles and unpublished dissertations from their inception to 2020. The unpublished dissertations were obtained from university website (http:// etd.aau.edu.et, http://erepository.uonbi.ac.ke). EndNote reference manager was used to remove the duplications of references before screening. Either in vitro studies or in vivo studies or clinical trials of herbal medicine on African medicinal plants were included. Studies were eligible for inclusion if they were conducted to determine antiviral activities using available scientific methods and conducted on medicinal plants in Africa. Studies conducted on medicinal plants outside of Africa were excluded from the study. Review articles and ethnobotanical studies were also excluded. Eligibility assessment was conducted by TB and SD independently and disagreement between authors was resolved by discussion.

In this study 316 publications were retrieved of which 36 (Ferrea et al., 1993; Beuscher et al., 1994; Vlietinck et al., 1995; Nakano et al., 1997; Kitamura et al., 1998; Hussein et al., 1999; Kudi and Myint, 1999; Sindambiwe et al., 1999; Anani et al., 2000; Yoosook et al., 2000; Cos et al., 2002b; Chiang et al., 2003; Wang et al., 2004; Bessong et al., 2005; Gebre-Mariam et al., 2006; Tolo et al., 2006; Kambizi et al., 2007; Maregesi et al., 2008; Duraipandiyan and Ignacimuthu, 2009; Gyuris et al., 2009; Ojo et al., 2009; Selvarani, 2009; Sunday et al., 2010; Astani et al., 2011; Nwodo et al., 2011; Sultana, 2011; Ndhlala et al., 2013; Ogbole et al., 2013; Kwena, 2014; David et al., 2017; Clain et al., 2018; Mehrbod et al., 2018; Nasr-Eldin et al., 2018; Ogbole et al., 2018; Cambaza, 2020; Gyebi et al., 2021) were included in the qualitative synthesis, Figure 1 .

Three hundred and twenty-eight plants were screened for antiviral activities of which 127 tested showed activities against 25 viral species; Among these were Poliovirus ( Tables 1-4) . Isolated compounds were also identified and their activities outlined, namely alkaloids (combretine and betonicine) from Combretum micrantum (Ferrea et al., 1993) , Aloin from Aloe ferox (Kambizi et al., 2007) , a polysaccharide from Aspalathus. Linearis (Nakano et al., 1997) , Asiaticoside from Centella asiatica (Yoosook et al., 2000) , Catechin from S. frutescens (Bessong et al., 2005) .

This study summarized the antiviral activities of African medicinal plants. Forty two African medicinal plants showed noteworthy activities against poliovirus and twenty four against HSV.

Medicinal Plants Used for Severe Acute Respiratory Syndrome For example, Madagascar produced an herbal drink from Artemisia annua called COVID Organics which was even exported abroad (Cambaza, 2020) . The anecdotal use of this product resulted in exaggerated claims of their efficacies that are not evidence-based. This calls for the urgent need for further research on this as well as all other herbal formulations on their efficacy through randomized controlled trials and identify their active ingredients, develop proven formulations and dosing protocols, and define pharmacokinetics, toxicology, and safety to enable drug development. Derivatives from the herb Artemisia annua have been used for the treatment of fevers, malaria, and respiratory tract infections. The WHO has offered to support the design of a study to assess the efficacy, safety, and dosage formulation of herbal formulations that may be useful against COVID-19 (Muhammad, 2020) . The WHO is currently helping the validation of some traditional medicine through clinical trials for the treatment of COVID-19 (Tih, 2020) .

Studies on TM use for COVID-19 produced many publications of which four were systematic reviews and metaanalyses entirely based on CHM (Liu et al., 2006; Fan et al., 2020; Liu et al., 2020; Xiong et al., 2020) and other systematic reviews and meta-analyses were not CHM (Ang et al., 2020) . Traditional medicine is being used to control coronavirus alone or in a combination with western medicine. A recent systematic review and meta-analysis of randomized controlled trials included seven randomized controlled trials and compared combined therapy of herbal medicine with Western medicine and western medicine alone (Ang et al., 2020) . This demonstrated the potential role of herbal medicine in treating and/or managing COVID-19 (Ang et al., 2020) . The other study which included 12 randomized controlled trials and one quasi-RCT with A total of 640 SARS-CoV-2 patients and 12 Chinese herbs did not indicate a significant difference in Chinese herbs combined with Western medicines versus Western medicines alone (Liu et al., 2006 ). Yet hundreds of Chinese traditional medicines had been widely used for the treatment of SARS and currently, it's being used for SARS-CoV-2 (Shahrajabian et al., 2020) . A recent review conducted by Attah et al. (2021) summarized 17 African medicinal plants studied against Covid-19 with viral protein targeted. The medicinal plants listed targeted SARS-Cov-2 3CLpro and ACE2.

An in silico screening was conducted on 62 alkaloids and 100 terpenoids from African medicinal plants against coronavirus 3chymotrypsin-like protease (3CL pro ), a highly defined hit-list of seven compounds. Furthermore, four nontoxic, druggable plant- derived alkaloids and terpenoids that bind to the receptorbinding site and catalytic dyad of SARS-CoV-2 3CL pro were identified. More than half of the selected top 20 alkaloids and terpenoids had a binding affinity for the 3CL pro of the SARScoronaviruses that surpassed reference inhibitors. The 6oxoisoiguesterin from Bisnorterpenes had the highest binding affinity to the 3CL pro of SARS-CoV-2 while 20-epi-isoiguesterinol from Bisnorterpenes, isoiguesterin from Bisnorterpenes, 20epibryonolic acid from Cogniauxia podolaena was the top docked compounds to 3CL pro of SARS-CoV and MERS-CoV. The study revealed that natural agents from the alkaloids and terpenoids class of compounds are capable of inhibiting the 3CL pro with a high inhibitory pattern to both SARS-CoV-2 and SARS-CoV (Gyebi et al., 2021 (Aanouz et al., 2021) . Crocin, a compound from Crocus Sativus, inhibited the replication of HSV (Soleymani et al., 2018) . Digitoxigenin is a compound from Nerium oleander and studied for its antiviral and anticancer activity (Boff et al., 2019) . B-Eudesmol was extracted from Lauris nobilis has significant antiviral activity (Astani et al., 2011) .

Medicinal plants target viruses through various mechanisms. Garcinia kola's A 13 components showed activity against Ebola virus probably by binding with membrane proteins, metalloproteases, and Ser/Thr Kinase through the three most featured targets; cannabinoid receptors, cyclin-dependent kinases, and matrix metalloproteinase. The components could also target cathepsin, collagenase, and another matrix metalloproteinase (King, 2000; Homsy et al., 2004; David et al., 2017) . Baicalin from (Scutellariae Radix), a natural product from the plant, acts on chemokine receptors and inhibits the entry of HIV (Kitamura et al., 1998; Li et al., 2000; Wang et al., 2004) . The N-butanol fraction of Bredelia micrantha showed reverse transcriptase inhibition activity. Terpenes showed an inhibitory effect against the protease enzyme (Hussein et al., 1999; Huang and Chen, 2002; Tolo et al., 2006; Yu et al., 2006) .

There are different targets for HIV drug developments. One is the viral envelope which plays a major role in infecting a cell by interacting with CD4 and chemokine receptors CCR5 and CXCR4. CV-N and Baicalin is a natural product from a plant source that acts on chemokine receptors and inhibits the entry of HIV (Kitamura et al., 1998; Li et al., 2000; Wang et al., 2004) . The reverse transcriptase enzyme is also a target for drug development. The study comparing organic solvent and an aqueous fraction of various medicinal plants, and the n-butanol fraction of Bredelia micrantha showed anti-reverse transcriptase activities. Phytochemicals such as terpenes revealed inhibitory effects against protease enzyme; an important enzyme for proteolytic processing of polyprotein precursor into essential proteins for the assembly of virus particles (Hussein et al., 1999; Huang and Chen, 2002; Yu et al., 2006) . Croton megalobotrys is a plant species which showed the latent HIV-1 reversal activity. Crude extractas of the plant was comparable with known LRA prostatin which induced HIV-1 in J-lat cells. From the fraction of the crude extract, two novel phorbol esters (Namusha1 and 2) were identified. The previous study also showed that multiple phorbol esters had anti-HIV-1 activities (El-Mekkawy et al., 2000) and function as LRAs (Tietjen et al., 2018) .

Medicinal plants have been widely used to treat the hepatitis virus. Out of five plants examined for anti-Hepatitis B virus, three exhibited anti-hepatitis B in vitro with a CC50 value of more than 100 μg/ml. These were aqueous extracts from Carissa edulis (Apocynaceae), Prunus africana Kalkman (Rosaceae) and the methanol extract from Acacia mellifera Benth (Fabaceae). Extracts of C. edulis exhibited the highest activity; an over 12.15% inhibition rate relative to the negative control. P. africana and A. mellifera extract demonstrated 5% inhibition and 2.15% inhibition respectively, relative to controls. Further confirmation of the activity of these plants using the quantitative real-time PCR technique showed the aqueous extract of C. edulis and the methanol extract of A. mellifera exhibited sustained activity over a range of plant extract concentrations from 31.25 μg/ml to 125 μg/ml. The evaluation of the EC 50 the two plant extracts exhibiting notable anti-HBV activity using this technique yielded; C. edulis' EC 50 was 331.6 μg/ml while that of A. mellifera was 295.0 μg/ml (Kwena, 2014) .

Influenza virus infection remains a major health problem for animals and humans. Medicinal plants are becoming increasingly popular and included in primary health care in different parts of the world. A study conducted on methanol, ethanol, acetone, hot and cold aqueous extract of five plants (Pittosporum viridiflorum, Cussonia spicata, Rapanea melanophloeos, Tabernaemontana ventricosa, Clerodendrum glabrum) against influenza A virus exhibited antiviral effect. Most effective result were obtained from Rapanea melanophloeos methanol leaf extract (EC 50 113.3 μg/ml) and Pittosporum viridiflorum methanol, 100 and 30% ethanol and acetone leaf extracts (EC 50 values 3.6, 3.4, 19.2, 82.3 μg/ml, respectively) (Mehrbod et al., 2018) . Ethiopian medicinal plants like Acokanthera schimperi, Euclea schimperi, leaf extracts of Inula confertiflora prevent influenza A virus replication and those of Melilotus elegans were active against influenza A virus (Gebre-Mariam et al., 2006) (Table 2) .

In sub-Saharan Africa, high prevalence rates between 60 and 80% in young adults have been recorded in population-based studies. It is usually managed by antiviral drugs such as a nucleoside analog acyclovir. However, resistance to ACV has been reported mainly among immunocompromised patients (Morfin and Frontiers in Pharmacology | www.frontiersin.org December 2021 | Volume 12 | Article 682794 Thouvenot, 2003) . Medicinal plants have been considered as an alternative for the development of a new drug to overcome the resistance to the modern drug. The study was conducted on an aqueous extract from the root bark of Carissa edulis (Apocynaceae) has shown significant anti-HSV activity in vitro and in vivo (Omino and Kokwaro, 1993) . The extract significantly inhibited the formation of plaques in Vero E6 cells infected with 100 PFU of the wild-type strains of HSV by 100% at 50 μg/ml in vitro with minimal cell cytotoxicity (Tolo et al., 2006) . The extracts from four plants; Lannea schweinfurthii, Combretum adenogonium, Ficus sycomorus, and Terminalia mollis showed strong antiviral activity against Herpes Simplex Virus type 1. Out of 42 Egyptian medicinal plants, Ephedra alata and Moringa peregrina are found to have antiviral activity against HSV. Also, the results revealed that Capparis sinaica, Tamarix nilotica, and Cyperus rotundus are found to have a virucidal effect against HSV (Soltan and Zaki, 2009 ). The current study is only a preliminary study where some studies reported naively. As all studies in vitro possible dose range, duration of action and in vivo pharmacodynamics properties cannot be established.

In conclusion, African medicinal plants pose significant antiviral activities and could potentially be candidates for viral disease treatment and/or management. It is imperative therefore that research on currently available African medicinal plants be highly recommended. Outcomes from such studies would potentially lead to breakthrough discoveries for the management and/or treatment of COVID-19 and various other viral infections upon appropriate optimization.

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

PO, AW, and CT conceived the idea. TB, SD, AM, NT, NA, and BL extracted data and critically reviewed the primary studies. TB and SD analyzed the data and wrote the first draft of the manuscript. All authors reviewed and approved the manuscript.

Moroccan Medicinal Plants as Inhibitors against SARS-CoV-2 Main Protease: Computational Investigations

Medicinal Plants Used in Traditional Medicine by Oromo People, Ghimbi District, Southwest Ethiopia

Use and Management of Medicinal Plants by Indigenous People of Ejaji Area (Chelya Woreda) West Shoa, Ethiopia: An Ethnobotanical Approach

Investigation of Medicinal Plants of Togo for Antiviral and Antimicrobial Activities

Herbal Medicine for the Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Screening for Antiviral Activities of Isolated Compounds from Essential Oils. Evid. Based Complement

Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine with COVID-19 in Focus: A Nigerian Perspective

The Antiviral Activity of Six South African Plants Traditionally Used against Infections in Ethnoveterinary Medicine

Evaluation of Selected South African Medicinal Plants for Inhibitory Properties against Human Immunodeficiency Virus Type 1

Reverse Transcriptase and Integrase

Antiviral Activity of African Medicinal Plants

Potential Anti-herpes and Cytotoxic Action of Novel Semisynthetic Digitoxigenin-Derivatives

The African Miracle: why COVID-19 seems to spread slowly in Sub-Saharan Africa

Anti-Herpes Simplex Virus Activity of Bidens Pilosa and Houttuynia Cordata

Extract from Aphloia Theiformis, an Edible Indigenous Plant from Reunion Island, Impairs Zika Virus Attachment to the Host Cell Surface

Further Evaluation of Rwandan Medicinal Plant Extracts for Their Antimicrobial and Antiviral Activities

Antiviral Activity of Rwandan Medicinal Plants against Human Immunodeficiency Virus Type-1 (HIV-1)

Bioinformatics Analysis of Garcinia Kola Active Components and Glycoproteins of Ebola Virus (Zaire Ebolavirus)

Antibacterial and Antifungal Activity of Flindersine Isolated from the Traditional Medicinal Plant, Toddalia Asiatica (L.) Lam

Anti-HIV-1 Phorbol Esters from the Seeds of Croton Tiglium

Chinese Herbal Medicine for COVID-19: Current Evidence with Systematic Review and Meta-Analysis

Assessing African Medicinal Plants for Efficacy and Safety: Pharmacological Screening and Toxicology

Antiviral Activities of Some Ethiopian Medicinal Plants Used for the Treatment of Dermatological Disorders

Potential Inhibitors of Coronavirus 3-chymotrypsin-like Protease (3CLpro): an In Silico Screening of Alkaloids and Terpenoids from African Medicinal Plants

Antiviral Activities of Extracts of Euphorbia Hirta L. Against HIV-1, HIV-2 and SIVmac251

Traditional Health Practitioners Are Key to Scaling up Comprehensive Care for HIV/AIDS in Sub-saharan Africa

Molecular Targets of Anti-HIV-1 Triterpenes

Inhibitory Effects of Sudanese Plant Extracts on HIV-1 Replication and HIV-1 Protease

Anti-viral Effects of Aqueous Extracts of Aloe Ferox and Withania Somnifera on Herpes Simplex Virus Type 1 in Cell Culture

Collaboration with Traditional Healers in HIV/AIDS Prevention and Care in Sub-saharan Africa: A Literature Review

Baicalin, an Inhibitor of HIV-1 Production In Vitro

Antiviral Activity of Some Nigerian Medicinal Plant Extracts

Anti-viral Activities of Selected Kenyan Medicinal Plants against the Hepatitis-B Virus

The Flavonoid Baicalin Exhibits Anti-inflammatory Activity by Binding to Chemokines

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies that Evaluate Health Care Interventions: Explanation and Elaboration

Efficacy and Safety of Integrated Traditional Chinese and Western Medicine for Corona Virus Disease 2019 (COVID-19): a Systematic Review and Meta-Analysis

Chinese Herbs Combined with Western Medicine for Severe Acute Respiratory Syndrome (SARS)

Identification of Antiviral Activity of Toddalia Asiatica against Influenza Type A Virus

Screening of Some Tanzanian Medicinal Plants from Bunda District for Antibacterial, Antifungal and Antiviral Activities

South African Medicinal Plant Extracts Active against Influenza A Virus

Herpes Simplex Virus Resistance to Antiviral Drugs

COVID-19 Pandemic: The Role of Traditional Medicine

Polysaccharide from Aspalathus Linearis with strong Anti-HIV Activity

Antibiofilm and Antiviral Potential of Leaf Extracts from Moringa Oleifera and Rosemary (Rosmarinus Officinalis Lam.). Egypt

In Vivo evaluation of the Antiviral Activity of Cajanus Cajan on Measles Virus

Anti-polio Virus Activity of Medicinal Plants Selected from the Nigerian Ethno-Medicine

Antiviral Properties of Two Nigerian Plants

Ethnobotany of Apocynaceae Species in Kenya

Multiple Inflammatory and Antiviral Activities in Adansonia Digitata (Baobab) Leaves, Fruits and Seeds

Influenza Virus Variants with Reduced Susceptibility to Inhibition by a Polyphenol Extract from Geranium Sanguineum L

Chinese Herbal Medicine for SARS and SARS-CoV-2 Treatment and Prevention, Encouraging Using Herbal Medicine for COVID-19 Outbreak

Screening of Seven Selected Rwandan Medicinal Plants for Antimicrobial and Antiviral Activities

Antiviral Effects of Saffron and its Major Ingredients

Antiviral Screening of Forty-Two Egyptian Medicinal Plants

Frontiers in Pharmacology | www.frontiersin.org

Ursolic Acid and Related Derivatives as Medicinally Important Natural Product

Antiviral Effect of Hibiscus sabdariffa and Celosia Argentea on Measles Virus

Croton Megalobotrys Müll Arg. And Vitex Doniana (Sweet): Traditional Medicinal Plants in a Three-step Treatment Regimen that Inhibit In Vitro Replication of HIV-1

The Croton Megalobotrys Müll Arg. Traditional Medicine in HIV/AIDS Management: Documentation of Patient Use

WHO Holds Meeting with African Traditional Medicine Experts

Anti-viral Activity of the Extracts of a Kenyan Medicinal Plant Carissa Edulis against Herpes Simplex Virus

In Vitro anti-viral Activity of Aqueous Extracts of Kenyan Carissa Edulis, Prunus Africana and Melia Azedarach against Human Cytomegalovirus

Ethnopharmacological Plants Used to Treat Hepatitis and Their Antioxidant Activity of District of Bobo-Dioulasso (Burkina Faso)

The 1918 "Spanish Flu" in Spain

Screening of Hundred Rwandese Medicinal Plants for Antimicrobial and Antiviral Properties

Zinc Coupling Potentiates Anti-HIV-1 Activity of Baicalin

Fifty-sixth world health assembly, Provisional agenda item 14

Cumulative Number of Reported Probable Cases of Severe Acute Respiratory Syndrome (SARS)

National Policy on Traditional Medicine and Regulation of Herbal Medicines: Report of a WHO Global Survey

Weekly Epidemiological Update on COVID-19 -3

Chinese Herbal Medicine for Coronavirus Disease 2019: a Systematic Review and Meta-Analysis

Antiherpes Simplex Virus Activities of Crude Water Extracts of Thai Medicinal Plants

Anti-AIDS Agents 69. Moronic Acid and Other Triterpene Derivatives as Novel Potent Anti-HIV Agents

Silico screening of Chinese Herbal Medicines with the Potential to Directly Inhibit

Effect of Integrated Traditional Chinese and Western Medicine on SARS: a Review of Clinical Evidence

Middle East Respiratory Syndrome

The authors would like to acknowledge Ambo University, Mbarara University of Science and Technology, and Hawassa University for their support of this article through providing access to the internet and databases for the review.

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Publisher's Note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.Copyright © 2021 Beressa, Deyno, Mtewa, Aidah, Tuyiringire, Lukubye, Weisheit, Tolo and Ogwang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.Frontiers in Pharmacology | www.frontiersin.org